Explainable AI for Predicting Hospital Admissions in Heart Failure: ExplAIn-HF
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Heart Failure. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Netherlands
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The goal of this observational study is to develop and validate an XAI based model that predicts HF events and identifies modifiable con-tributing factors, and to evaluate the added value of integrating high frequency smartwatch data compared to usual care in patients with heart failure. The main objectives of the study are: 1. To develop and validate an XAI based model that predicts HF events and identifies modifiable contributing factors, and to evaluate the added value of integrating high frequency smartwatch data compared to usual care. In the Netherlands usual care includes remote monitoring of heartrate, blood pressure, weight and symptoms. 2. To include insights of the smartwatch into activity patterns, impact on quality of life (KCCQ-12), and patient satisfaction with net promoter score (NPS). Participants will wear a smartwatch for six months and perform an I-lead ecg with the smartwatch weekly.
Primary outcome measures
- Heart failure (HF) event [Time frame: From enrollment to the end of follow-up at 6 months]
Secondary outcome measures (3)
- Activity patterns [Time frame: From enrollment to the end of follow-up at 6 months]
- Quality of life (QoL) [Time frame: Measured at baseline and at the end of follow-up at 6 months. The Kansas City Cardiomyopathy Questionnaire is scored on a scale of 0 to 100; higher scores indicate better health.]
- Net promotor score [Time frame: At the end of follow-up at 6 months]
Eligibility criteria
Inclusion criteria
- Adult HF patients
- NYHA class II, or NYHA III
- Recent rehospitalization for HF
- Usual care with active participation in the telemonitoring program "Zorg Bij Jou" (ZBJ)
- Possession of an iPhone 11 or newer and compatible with the study apps
Exclusion criteria
- Lack of digital literacy or inability to use the device
- Not capable to sign consent
- Referral to hospice
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Netherlands · 1 center
- Medisch Spectrum Twente — Enschede
Identifiers
NCT: NCT07689760 · Explain-HF